---
id: idsa-ssti-2014
title: "IDSA Practice Guidelines for Diagnosis and Management of Skin and Soft Tissue Infections"
short_title: "IDSA SSTI 2014"

organization: Infectious Diseases Society of America
collaborators: null
country: US
url: https://academic.oup.com/cid/article/59/2/e10/2895845
doi: 10.1093/cid/ciu444
pmid: 24973422
open_access: true

specialty: infectious-disease
guideline_type: clinical-practice
evidence_system: other
conditions:
  - skin and soft tissue infections
  - SSTI
  - cellulitis
  - necrotizing fasciitis
tags:
  - MRSA
  - incision and drainage
  - surgical emergency
  - clindamycin

publication_date: 2014-07-15
previous_version_date: 2011-02-01
status: current
supersedes: idsa-ssti-2011
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-22
---

# IDSA Practice Guidelines for Diagnosis and Management of Skin and Soft Tissue Infections

## Scope
Comprehensive guidelines for diagnosis and treatment of skin and soft tissue infections (SSTIs) ranging from superficial infections to life-threatening necrotizing fasciitis.

## Key Recommendations

### Impetigo and Ecthyma
- **Limited lesions**: Topical mupirocin or retapamulin
- **Numerous lesions or outbreak**: Oral antibiotics (dicloxacillin, cephalexin)
- If MRSA suspected: Doxycycline, clindamycin, or TMP-SMX
- Duration: 7 days

### Purulent Cellulitis/Skin Abscess

#### Abscess Management
- **Primary treatment**: Incision and drainage (I&D)
- **Antibiotics after I&D**: Recommended if:
  - Multiple lesions
  - Extensive surrounding cellulitis
  - Immunocompromise
  - Systemic signs (fever, tachycardia)
  - Inadequate response to I&D alone

#### MRSA Coverage
- TMP-SMX, doxycycline, or clindamycin
- Duration: 5-10 days

### Non-Purulent Cellulitis

#### Mild (No Systemic Signs)
- Oral antibiotics targeting beta-hemolytic streptococci
- Penicillin VK, cephalexin, dicloxacillin, or clindamycin
- Duration: 5-6 days

#### Moderate (Systemic Signs)
- IV antibiotics: Penicillin G, ceftriaxone, cefazolin, or clindamycin
- Convert to oral when improving

#### Severe (Sepsis, Immunocompromised, Failed Oral)
- Vancomycin + piperacillin-tazobactam
- Broad coverage until organism identified

### Necrotizing Fasciitis

#### Recognition
- Pain out of proportion to exam
- Rapid progression
- Systemic toxicity, crepitus, bullae
- High mortality without prompt surgery

#### Management
- **Surgical emergency**: Urgent debridement (within hours)
- Broad-spectrum antibiotics: Vancomycin + piperacillin-tazobactam (or carbapenem) + clindamycin
- Clindamycin for toxin suppression
- Repeat debridement as needed

### Bite Wounds

#### Dog/Cat Bites
- Amoxicillin-clavulanate (covers Pasteurella, anaerobes)
- Alternative: Doxycycline or TMP-SMX + metronidazole

#### Human Bites
- Amoxicillin-clavulanate
- Covers Eikenella corrodens

### Surgical Site Infections
- Source control (open wound, drain abscess)
- Antibiotics based on likely pathogens and local resistance

## Special Populations

### Diabetes-Related Foot Infections
- Mild: Oral antibiotics, narrow spectrum
- Moderate/Severe: IV antibiotics, broad spectrum
- Osteomyelitis workup if deep or chronic
- See separate 2023 IDSA guideline for DFI

### Immunocompromised
- Lower threshold for hospitalization
- Broader empiric coverage
- Consider opportunistic pathogens

## Duration of Therapy
- Uncomplicated cellulitis: 5-6 days
- Abscess after I&D: 5-10 days
- Necrotizing infection: Until debridement complete + clinical improvement
